Predictors of methamphetamine injection in out-of-treatment IDUs

Substance Use and Misuse

Volumn 44, Issue 3, 2009, Pages 332-342

  Corsi, Karen F ^a,b   Kwiatkowski, Carol F ^a   Booth, Robert E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Drug injection; Hepatitis C; HIV risk; Methamphetamine; Peer education

Indexed keywords

ADULT; AMBULATORY CARE; COLORADO; DOPAMINE AGENTS; FEMALE; HEPATITIS C; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; METHAMPHETAMINE; MIDDLE AGED; ODDS RATIO; PEER GROUP; RISK ASSESSMENT; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 61649128794     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802344765     Document Type: Article

References (42)

1. Anglin, M. D., Burke, C., Perrochet, B., Stamper, E., Dawud-Noursi, S. (2000). History of the methamphetamine problem. Journal of Psychoactive Drugs 32(2):137-141.
2. Boddiger, D. (2005). Methamphetamine use linked to rising HIV transmission. The Lancet 365:1217-1218.
3. Booth, R. E. (1995). Gender differences in high-risk sex behaviors among heterosexual drug injectors and crack smokers. American Journal of Drug & Alcohol Abuse 21(4):419-432.
4. Buchacz, K., McFarland, W., Kellogg, T. A., Loeb, L., Holmberg, S. D., Dilley, J., et al. (2005). Amphetamine use is associated with increased HIV incidence in men who have sex with men in San Francisco. AIDS 19:1423-1438.
5. Cherner, M., Letendre, S., Heaton, R. K., Durelle, J., Marquie-Beck, J., Gragg, B., et al. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64:1343-1347.
6. Colfax, G., Coates, T. J., Husnik, M. J., Huang, Y., Buchbinder, S., Koblin, B., et al. (2005). Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health 82(1):I62-I70.
7. Copeland, A. L., Sorensen, J. L. (2001). Differences between methamphetamine users and cocaine users in treatment. Drug and Alcohol Dependence 62:91-95.
8. Corsi, K. F., Kwiatkowski, C. F., Booth, R. E. (2002). Predictors of positive outcomes for out-of-treatment opiate injectors recruited intomethadone maintenance through street outreach. Journal of Drug Issues (Summer): 99-1016.
9. Des Jarlais, D. C., Paone, D., Milliken, J., Turner, C. F., Miller, H., Gribble, J., et al. (1999). Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. The Lancet 353(9165):1657-1661.
10. Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Andersen, M., et al. (1994). Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1(4):383-392.
11. Farabee, D., Prendergast, M., Cartier, M. A. (2002). Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs 34(3):295-300.
12. Gibson, D. R., Leamon, M. H., Flynn, N. (2002). Epidemiology and public health consequences of methamphetamine use in California's Central Valley. Journal of Psychoactive Drugs 34(3):313-319.
13. Jones, K. (2005). Methamphetamine, the brain, HIV, and mental health. Focus: A Guide to AIDS Research and Counseling 20(6):1-8.
14. Klee, H. (1993). HIV risks for women drug injectors: heroin and amphetamine users compared. Addiction 88:1055-1062.
15. Latkin, C. A., Vlahov, D., Anthony, J. C. (1993). Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 88(4):517-526.
16. Lessler, J. T., Caspar, R. A., Penne, M. A., Barker, P. R. (2000). Developing computer assisted interviewing (CAI) for the National Household Survey on Drug Abuse. Journal of Drug Issues 30(1):9-34.
17. Letendre, S. L., Cherner, M., Ellis, R., Marquie-Beck, J., Gragg, B., Marcotte, T., et al. (2005). The effects of Hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS 19(Suppl. 3), S72-S78.
18. Lineberry, T. W., Bostwick, J. M. (2006). Methamphetamine abuse: A perfect storm of complications. Mayo Clinic Proceedings 81(1):77-84.
19. Lorvick, J., Martinez, A., Wenger, L., Gee, L., Kral A. (2005). Methamphetamine use among female injectors in San Francisco. Presented at the First National Conference on Methamphetamine, HIV, and Hepatitis, Salt Lake City, UT.
20. Molitor, F., Ruiz, J. D., Flynn, N., Mikanda, J. N., Sun, R. K., Anderson, R. (1999). Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug and Alcohol Abuse 25(3):475-497.
21. Molitor, F., Truax, S. R., Ruiz, J. D., Sun, R. K. (1998). Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. Western Journal of Medicine 168(2):93-97.
22. National Institute on Drug Abuse. (2005). NIDA InfoFacts: Costs to Society. NIDA InfoFacts.
23. National Institute on Drug Abuse. (2006). Methamphetamine abuse and addiction. Research Report Series NIH Publication Number 06-4210.
24. Rawson, R. A., Washton, A., Domier, C. P., Reiber, C. (2002). Drugs and sexual effects: role of drug type and gender. Journal of Substance Abuse Treatment 22:103-108.
25. Rawson, R., Huber, A., Brethen, P., Obert, J., Gulati, V., Shoptaw, S., et al. (2000). Methamphetamine and cocaine users: differences in characteristics and treatment retention. Journal of Psychoactive Drugs 32(2):233-238.
26. Reback, C. J. (1999). HIV risk behaviors of gay and bisexual male methamphetamine users contracted through street outreach. Journal of Drug Issues 29:155-166.
27. Semple, S. J., Patterson, T. L., Grant, I. (2004). Determinants of condom use stage of change among heterosexually-identified methamphetamine Users. AIDS and Behavior 8(4):391-400.
28. Shillington, A. M., Cottler, L. B., Mager, D. E., Compton III, W. M. (1995). Self-report stability for substance use over 10 years: data from the St. Louis Epidemiologic Catchment Study. Drug & Alcohol Dependence 40:103-109.
29. Shoptaw, S., Reback, C. J., Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. Journal of Addictive Diseases 21(1):91-105.
30. Shoptaw, S., Reback, C. J., Peck, J. A., Yang, X., Rotheram-Fuller, E., Larkins, S., et al. (2005). Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence 78(2):125-134.
31. Substance Abuse and Mental Health Service Administration (SAMHSA). (2005). Methamphetamine use, abuse, dependence: 2002, 2003, 2004. The NSDUH Report.
32. Substance Abuse and Mental Health Services Administration. (2007a). Drug abuse warning network, 2005: national estimates of drug-related emergency department visits. Rockville, MD: SAMHSA, Office of Applied Studies, DHHS Publication No. (SMA) 07-4256. (DAWN; D-29).
33. Substance Abuse and Mental Health Services Administration. (2007b). The national survey on drug use and health report: methamphetamine use. Rockville, MD: SAMHSA, Office of Applied Studies.
34. Turner, C. F., Ku, L., Rogers, S. H., Lindberg, L. D., Pleck, J., Sonenstein, F. L. (1998). Adolescent sexual behavior, drug user and violence: Increased reporting with computer survey technology. Science 280:847-873.
35. Twitchell, G. R., Huber, A., Reback, C. J., Shoptaw, S. (2002). Comparison of general and detailed HIV risk assessments among methamphetamine abusers. AIDS and Behavior 6(2):153-162.
36. United States Department of Justice. (2006). National drug threat assessment 2007: methamphetamine. Available at www.usdoj.gov/dea/concern/18862/ meth.htm.
37. Urbina, A., Jones, K. (2004). Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clinical Infectious Disease, 38(6):890-894.
38. Van Gorp, W. G., Hinkin, C. H. (2005). Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine. Neurology 64:1328-1329.
39. Watters, J. K., Biernacki, P. (1989). Targeted sampling: options for the study of hidden populations. Social Problems 36(4):416-430.
40. Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., et al. (1994). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning 17(4):347-355.
41. Wohl, A. R., Johnson, D. F., Lu, S., Jordan, W., Beall, G., Currier, J., et al. (2002). HIV risk behaviors among African Americanmen in Los Angeles County who self-identify as heterosexual. Journal of Acquired Immune Deficiency Syndromes 31:354-360.
42. Zule, W. A., Desmond, D. P. (1999). An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. American Journal of Drug & Alcohol Abuse 25(1):1-23.